Podcast: SubQ Solutions: Induction and Maintenance in Moderately to Severely Active CD and UC
In this episode of RhAPPcast, host Amanda Mixon, PA-C, is joined by Christina Hanson, NP, to explore the growing intersection between rheumatology and gastroenterology, focusing on shared immune pathw...
31 Maalis 23min
FAQ: Treat Through VS Randomized Withdrawal Design: What's The Difference?
Thank you to Johnson & Johnson for the support on this FAQ Video Module.In this FAQ video module, Tedra Gray, a gastroenterology nurse practitioner at Sinai Chicago, breaks down the key differences be...
24 Maalis 3min
Medication Review: GALAXI & GRAVITI Clinical Trials & LTE Data
Thank you to Johnson & Johnson for the support on this Medication Review Video Module. In this medication review video module, Kimberly Orleck, PA-C, reviews the long-term efficacy and safety of gusel...
17 Maalis 5min
Podcast: Inflammation Intersection: A Rheum-Gi Dialogue
In this podcast, host Amanda Mixon, PA-C, leads a 2026 Fireside Chat exploring the intersection of rheumatology and gastroenterology. Joined by Kim Orleck, PA-C (GI APP), and Wendy Simmons, PA-C (Rheu...
10 Maalis 36min
Journal Club: Risankizumab Long-Term Efficacy in Crohn’s Disease: FORTIFY Extension Results
Thank you to AbbVie for the support on this Journal Club Review Video Module.In this journal club review, Kimberly Orleck, PA-C, discusses the long-term efficacy and safety of risankizumab, an IL-23 p...
24 Helmi 7min
Podcast: Upadacitinib FDA Label Update: What Clinicians Need to Know
Thank you to AbbVie for the support on this podcast episode.In this GHAPP podcast episode, Brooke Hodnik, PA, and Jamie Brogan, APRN, discuss the October 10, 2025 FDA label update for upadacitinib in ...
17 Helmi 15min
FAQ: Biomarkers: The Non-Invasive Future of HCC Detection
Thank you to Fujifilm for their support on this FAQ Video Module.In this FAQ video module, Patrick Horne, NP, President of GHAPP and nurse practitioner at the University of Florida, provides a clear, ...
12 Helmi 1min
FAQ: Approved Systemic Therapy in Upadacitinib’s Expanded UC and CD Indications
Thank you to AbbVie for their support on this FAQ Video Module. In this FAQ video module, Brooke Hodnick, PA-C, breaks down key updates to the expanded upadacitinib label for adults with moderate to s...
10 Helmi 2min
